Kara Davis, D.O. is an Assistant Professor of Pediatrics in the Division of Hematology and Oncology. Dr. Davis obtained her B.A. from Pennsylvania State University and her D.O. from the Philadelphia College of Osteopathic Medicine. Clinically, she completed her training in Pediatrics at Thomas Jefferson University/A.I. DuPont Children?s Hospital and her Heme/Onc fellowship at Lucile Packard Children?s Hospital at Stanford. During her fellowship training, Kara worked in the laboratory of Garry Nolan, Ph.D. where she utilized single-cell, high-dimensional analysis platforms to study healthy human B cell development and B cell leukemia. Her research focuses on using single-cell analysis to organize tumor heterogeneity in pediatric cancers, especially blood cancers, as means to determine cell populations associated with clinical risks such as relapse. Clinically, Dr. Davis sees patients with leukemia and is involved with the Cancer Cellular Therapies program with experience in treating children with chimeric antigen receptor (CAR) T-cells and other immunotherapies including checkpoint inhibitors.
- Pediatric Hematology-Oncology
Vice Chair, COG Study ADVL1412, Children's Oncology Group (2016 - Present)
Fellowship:Lucile Packard Children's Hospital (2010) CA
Residency:Thomas Jefferson University/AI duPont Hospital (2007) DE
Medical Education:Philadelphia College of Osteopathic Medicine (2004) PA
Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (2011)
Board Certification: Pediatrics, American Board of Pediatrics (2007)